Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- Frontiers: Editorial -Antioxidants in Mitigating Oxidative Stress-Induced Damage (Aune Lab)
- Dr. Raushan Kurmasheva’s laboratory has been awarded a $400K NCI SBIR Phase II grant titled “Enhanced overall survival in high-risk pediatric tumors using a novel oral small molecule.”
- Star Protocols: Transformer and graph variational autoencoder to identify microenvironments: A deep learning protocol for spatial transcriptomics (Chen)
- Cancer Research: Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Anti-tumor Immunity (Rao, Zhou, Hromas, Sung, Chen, et al)
- Cancer Research: Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Anti-tumor Immunity (Rao, Zhou, Hromas, Sung, Chen
Events
Greehey CCRI Spring Seminar Series: Min Kyu Kim, PhD, MS (UTHSA)
Presentation title: “Regulation of BRCA-1 Phosphorylation in Genome Repair.”
Greehey CCRI Spring Seminar Series: Uttiya Basu, PhD (Columbia)
Presentation title: Somatic Hypermutation Mechanisms in B-Cell Immunity and Cancer